TRVI - Trevi Therapeutics' (TRVI) CEO Jennifer Good on Q1 2021 Results - Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Jennifer Good – President and Chief Executive Officer Bill Forbes – Chief Development Officer Conference Call Participants Annabel Samimy – Stifel Gary Nachman – BMO Capital Markets Serge Belanger – Needham & Company Presentation Operator Good afternoon, and welcome to the Trevi Therapeutics First Quarter 2021 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event maybe recorded. Various remarks that management makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important

For further details see:

Trevi Therapeutics' (TRVI) CEO Jennifer Good on Q1 2021 Results - Earnings Call Transcript